Helmi Bin Dol, 47, shared his journey with colorectal cancer at the launch of the drug, and described how it has given him the precious gift of time with his family.
An oral targeted therapy proven to extend overall survival in patients with advanced colorectal cancer is now available in Malaysia.
IT has been estimated that one in 33 Malaysians is at risk of developing colorectal cancer, making it the second most common form of cancer affecting Malaysians today.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
